[1] DEFRONZO RA, FERRANNINI E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease[J]. Diabetes Care, 1991, 14(3):173-194.[2] LOVEJOY JC, SMITH SR, CHAMPAGNE CM, et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults[J]. Diabetes Care, 2002, 25(8):1283- 1288.[3] MARTIN JF, JOHNSTON CS, HAN CT, et al. Nutritional origins of insulin resistance: a rat model for diabetes-prone human populations[J]. J Nutr, 2000, 130(4):741-744.[4] STORLIEN LH, OAKES ND, PAN DA, et al. Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex[J]. Diabetes, 1993, 42(3):457- 562.[5] VESSBY B, UNSITUPA M, HERMANSEN K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study[J]. Diabetologia, 2001, 44(3):312- 319.[6] BARKER DJ, ERIKSSON JG, FORSEN T, et al. Fetal origins of adult disease: Strength of effects and biological basis[J]. Int J Epidemiol, 2002, 31(6):1235-1239.[7] NATHANIELSZ PW, POSTON L, TAYLOR PD. In utero exposure to maternal obesity and diabetes: Animal models that identify and characterize implications for future health[J]. Clin Perinatol, 2007, 34(2):515-526.[8] BISPHAM J, GOPALAKRISHNAN GS, DANDREA J, et al. Maternal endocrine adaptation throughout pregnancy to nutritional manipulation: Consequences for maternal plasma leptin and cortisol and the programming of fetal adipose tissue development[J]. Endocrinology, 2003, 144(8):3575-3585.[9] BENYSHEK DC, JOHNSTON CS, MARTIN JF. Post-natal diet determines insulin resistance in fetally malnourished, low birthweight rats (F1) but diet does not modify the insulin resistance of their offspring (F2) [J]. Life Sci, 2004, 74(24):3033-3041.[10] SYMONDS ME, PEARCE S, BISPHAM J, et al. Timing of nutrient restriction and programming of fetal adipose tissue development[J]. Proc Nutr Soc, 2004, 63(3):397-403.[11] BETRAM C, HANSON MA. Animal models and programming of the metabolic syndrome[J]. Br Med Bull, 2001, 60(1):103-121.[12] HOLEMANS K, AERTS L, VAN ASSCHE FA. Fetal growth and long-term consequences in animal models of growth retardation[J]. Eur J Obstet Gynecol Reprod Biol, 1998, 81(2):149-156.[13] PETRY CJ, OZANNE SE, HALES CN. Programming of intermediary metabolism[J]. Mol Cell Endocrinol, 2001, 185(1-2):81-91.[14] VAN ASSCHE FA, HOLEMANS K, AERTS L. Long-term consequences for offspring of diabetes during pregnancy[J]. Br Med Bull, 2001, 60:173-182.[15] LOWELL BB, SHULMAN GI. Mitochondrial dysfunction and type 2 diabetes[J]. Science, 2005, 307(5708):384-387.[16] Shelley P, Martin-Gronert MS, Rowlerson A, et al. Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice[J]. Am J Physiol Regul Integr Comp Physiol, 2009, 297(3):R675-681.[17] DEFRONZO RA, JACOT E, JEQUIER E, et al. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization[J]. Diabetes, 1981, 30(12):1000-1007. [18] KELLEY D, Mandarino L. Fuel selection in human skeletal muscle in insulin resistance: a re-examination[J]. Diabetes, 2000, 49(5):677-683. [19] STANNARD SR, JOHNSON NA. Insulin resistance and elevated triglyceride in muscle: more important for survival than ‘‘thrifty’’ genes? [J] J Physiol, 2004, 554(3):595-607.[20] GOOSSENS GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance[J]. Physiol Behav, 2008, 94(2):206-218.[21] STANNARD SR, JOHNSON NA. Insulin resistance and elevated triglyceride in muscle: more important for survival than ‘‘thrifty’’ genes[J]? J Physiol, 2004, 554(3):595-607.[22] MATSUDA M, DEFRONZO RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp[J]. Diabetes Care, 1999, 22(9):1462-1470. [23] KELLEY DE, HE J, MENSHIKOVA EV, et al. Dysfunction of mitochondria in human skeletal muscle in Type 2 Diabetes[J]. Diabetes, 2002, 51(10):2944-2950.[24] RUGH, R. The mouse: Its reproduction and development[M]. Oxford: Oxford university press 1990.[25] BUUS CL, POURAGEAUD F, FAZZI GE, et al. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries[J]. Circ Res, 2001, 89:180-186.[26] INOUE H, NOJIMA H, OKAYAMA H. High efficiency transformation of Escherichia coli with plasmids[J]. Gene, 1990, 96(1):23-28.[27] BIRNBOIM HC, DOLY J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA[J]. Nucleic Acids Res, 1979, 7(6):1513-1523.[28] FRACKMAN S, KEPHART D. Rapid ligation for the pGEM?-T and pGEM?-T Easy Vector Systems Promega notes. 1999, 71:08-12.[29] BOON RL. Developmental origins of health and disease[J]. Arch Dis Child 2006, 91:1046.[30] SAMUELSSON AM, MATTHEWS PA, ARGENTON M, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance a novel murine model of developmental programming[J]. Hypertension, 2008, 51:383-392.[31] HENRIKSEN EJ, KINNICK TR, TEACHEY MK, et al. Modulation of muscle insulin resistance by selective glycogen synthase kinase-3 inhibition in Zucker diabetic fatty rats[J]. Am J Physiol Endocrinol Metab, 2003, 284(5):E892-900.[32] GREFTE S, KUIJPERS-JAGTMAN AM, TORENSMA R, et al. Skeletal muscle development and regeneration[J]. Stem Cells Dev, 2007, 16(5):857-868.[33] DU M, YAN X, TONG JF, et al. Maternal obesity, inflammation, and fetal skeletal muscle development[J]. Biol Reprod, 2010, 82(1):4-12.[34] BUCKINGHAM M, BAJARD L, CHANG T, et al. The formation of skeletal muscle: from somite to limb[J]. J Anat, 2003, 202(1):59-68.[35] LI H, CHOUDHARY SK, MILNER DJ, et al. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin[J]. J Cell Biol, 1994, 124 (5):827-841. [36] JAYNES JB, CHAMBERLAIN JS, BUSKIN JN, et al. Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts[J]. Mol Cell Biol, 1986, 6(8):2855-2864.[37] KAHN BB, FLIER JS[J]. Obesity and insulin resistance. J Clin Invest, 2000, 106(4):473-481.[38] GREGOIRE FM, SMAS CM, SUL HS. Understanding adipocyte differentiation[J]. Physiol Rev, 1998, 78(3):783-809. [39] BIRON-SHENTAL T, SCHAIFF WT, RATAJCZAK CK, et al. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts[J]. Am J Obstet Gynecol, 2007, 197(5):516.e1-e6.[40] SAMUELSSON L, STR?MBERG K, VIKMAN K, et al. The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development[J]. EMBO J, 1991, 10(12):3787-3793.[41] LEE K, VILLENA JA, MOON YS, et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1) [J]. J Clin Invest, 2003, 111(4):453-461.[42] Rantanen J, Hurme T, Lukka R, et al. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells[J]. Lab Invest, 1995, 72(3):341-347. |